AZELASTIN FLUTICASON Mepha 0.14/0.05mg 23 ml
7680687300018
CH-68730
R01AD58
12.02.2.
1 / 3
google
Details
- Product number
- 6873001
- CPT
- -
- Packaging group
- 23
- Unit
- ml
- Composition
- azelastini hydrochloridum 0.137 mg, fluticasoni propionas 0.05 mg, cellulosum microcristallinum et carmellosum natricum, glycerolum, polysorbatum 80, dinatrii edetas, alcohol phenylethylicus, benzalkonii chloridum 0.014 mg, aqua purificata, ad suspensionem pro dosi, doses pro vase 120.
Articles (1)
Azelastin-Fluticason-Mepha, Nasenspray, Suspension
Nasenspray
23
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.137 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
0.05 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
0.014 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 31.20
Specialties list
Yes
Generic
Yes
SL addition date:
01/10/2024
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 68730
- Drug name
- Azelastin-Fluticason-Mepha, Nasenspray, Suspension
- Galenic form
- NASSS
- ATC Code
- R01AD58
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 11/05/2023
- Authorization expiration date
- 10/05/2028
- IT number
- 12.02.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- AZELASTIN FLUTICASON Mepha 0.14/0.05mg 23 ml
- Description (DE)
- AZELASTIN FLUTICASON Mepha 0.14/0.05mg 23 ml
- Market launch
- 11/05/2023
- Narcotic (BTM)
- No